StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > News is out

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Feb 16, 2021 7:34pm

232 Views

Post# 32580769

RE:News is out

Whoot whoot.

Nailbiter1 wrote:

Finally we get some news.
This stock is ready to fire-off on all cylinders now. Should have a great opening tomorrow...
TORONTO, ON / ACCESSWIRE / February 16, 2021 / StageZero Life Sciences (TSX:SZLS), a company dedicated to the early detection of cancer and multiple disease states through whole blood, is happy to announce that Chairman and CEO, James Howard-Tripp, is recovering at home from a successful surgical procedure. The CEO and Chief Groove Enhancer had two ingrown toenails removed without complications. "The swelling should go down in a few days. I'll be able to lace up my baseball cleats and resume kicking some serious heads" said Howard-Tripp.